All Activity

Our ability to connect is what really makes us unique. We respect your privacy, are aware of Indian culture, and are skilled in fostering a welcoming, judgment-free atmosphere. Our independent Russian Escort Service in Dwarka is made to surpass your expectations, whether you are a busy professional seeking stress relief or someone who wants to explore new fantasies.

This article highlights how women are shaping Oregon’s cannabis industry through leadership, education, and community events. Tokeativity and Women Leaders in Cannabis create valuable spaces for connection and business growth in Southern Oregon. Building supportive communities is important in every industry, much like Wordle Unlimited brings people together through a simple daily word challenge.

A Drug Enforcement Administration (DEA) hearing on the Trump administration’s cannabis rescheduling proposal has concluded, and the agency judge overseeing the proceedings has laid out a timeline for participating parties to file post-hearing briefs ahead of his own forthcoming recommendation on the reform. The multi-day hearing, which began late last month, wrapped up on Wednesday following the end of a presentation by a handful of states that oppose the federal cannabis reform. DEA Chief Administrative Law Judge Derek Julius on Thursday issued an order saying that because “no time was allotted for closing arguments” during the in-person court days, participants in the proceedings will be able to file post-hearing briefs—and they are due by August 17. Those documents can be a maximum of 50 pages in length and can include “closing arguments and argument on any other issue noted by the tribunal during the hearing.” “This is a nonmandatory submission; therefore, a Designated Party will not be penalized for not filing a post-hearing brief, and the absence of a submission implies that no submission was intended,” Julius wrote. His order also says that participants may submit proposed corrections to daily transcripts from the proceedings by August 17. “Corrections submitted by Designated Parties are only proposed corrections. This tribunal will also review the transcript for possible errors and note where corrections are needed,” the judge wrote. “The list created by the tribunal will be compared to the list(s) submitted by the Designated Parties to create a final corrections list. Following that, this tribunal will issue an order adopting the final list of corrections and will adopt those corrections into the official copy of the transcript.” “A fully corrected copy of the transcript of these proceedings will be made available to the public on the Agency’s website,” Julius said. The judge noted in his closing remarks at the end of the hearing on Wednesday that after he receives the forthcoming briefs he will work on writing his own recommendation on whether the government should move ahead with broad marijuana rescheduling—but stressed that the final decision will ultimately be up to the DEA administrator. Julius did not lay out an expected timeline for either his recommendation of the administrator’s action. During the hearing, DEA officials charged with defending the cannabis rescheduling proposal highlighted testimony on marijuana’s medical benefits and its relative safety compared to other substances such as alcohol and opioids. That included appearances from a Food and Drug Administration (FDA) scientist and a medical doctor from New Hampshire who detailed how medical marijuana provides relief to pain patients and can serve as an alternative to opioids. Meanwhile, lawyers and witnesses for parties who are oppose marijuana rescheduling and participated in the hearing put significant focus on the alleged harms of cannabis use as well as criticism of recently adopted changes to an analysis used to determine whether drugs have accepted medical value. DEA Administrator Terrance Cole invited only organizations and people who oppose marijuana reform to join the hearing as designated participants—telling supporters that they do not meet the definition of an “interested person” to participate because they are not “adversely affected or aggrieved by any rule or proposed rule issuable.” Opposition parties that participated include Smart Approaches to Marijuana, National Drug & Alcohol Screening Association, Tennessee Bureau of Investigation, DUID Victim Voices, Kenneth Finn, Phillip A. Drum and the states of Idaho, Indiana and Nebraska. Ahead of the hearing’s start last month, marijuana reform activists held a press conference outside DEA headquarters to highlight how they feel the have been “shut out” of the process—criticizing the fact that no supporters of reform were invited to participate and that the proceedings were not livestreamed despite officials’ vows of “transparency.” Marijuana Moment sent requests to DEA Chief Administrative Law Judge Derek Julius and to Cole, the DEA administrator, requesting they reverse a decision to prohibit the public from tuning into the cannabis hearing via livestream. A congressman and other journalists later joined in that request. — Marijuana Moment’s journalism is made possible by readers like you who value this work enough to support us with monthly pledges on Patreon. If you rely on our reporting to stay informed about key cannabis developments, please help us keep doing this by becoming a sustaining subscriber today. Backing us at the $25/month level also gets you access to our Bill Tracker so you won’t miss any important marijuana legislation in your state. — Acting Attorney General Todd Blanche in April issued an order that immediately reclassified state-licensed medical cannabis, as well as marijuana products approved by the Food and Drug Administration (FDA) from Schedule I of the Controlled Substances Act (CSA) to Schedule III. Under a separate order the acting attorney general signed, the hearing is being held to consider more comprehensively moving marijuana to Schedule III. A prior hearing process on the marijuana rescheduling process that was initiated by the Biden administration stalled last year amid litigation over alleged improper communications and witness selection. The current marijuana rescheduling process is being challenged with several lawsuits that have been consolidated by a federal appeals court. Those pieces of litigation against the cannabis reform have been filed by state attorneys general, marijuana legalization opponents and a cannabis-focused biopharmaceutical corporation. Meanwhile, the already-enacted rescheduling of state-licensed medical cannabis is already having broad impacts. The Congressional Research Service published a report on the current cannabis rescheduling move explaining that certified patients who possess medical marijuana from state-licensed dispensaries now have certain protections under Schedule III. “The order appears to authorize end users to possess marijuana for medical use without a CSA-compliant prescription,” it says. The Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has posted a draft update to a gun purchase form to acknowledge the federally legal status of medical marijuana under rescheduling. The revised section in question notably says that only “use or possession of marijuana for recreational purposes” is federally prohibited, leaving out the prior form’s mention of medical cannabis. The U.S. Department of the Treasury and Internal Revenue Service (IRS) said they plan to issue new tax guidance for the marijuana industry following rescheduling. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions they’re currently barred from under an IRS code known as 280E that doesn’t apply to Schedule III substances. Even DEA, which has long opposed cannabis legalization and was accused of stalling the rescheduling process initiative by the Biden administration, has launched a registration process for state-legal marijuana businesses to take advantage of federal benefits that come with the reform. The Department of Transportation, on the other hand, issued guidance saying that use of state-legal medical cannabis is still no excuse for a positive drug test by truck drivers, pilots and other safety-sensitive workers. The Department of War issued a memo making clear that marijuana use by military service members and civilian employees of the department remains prohibited, even under federal cannabis rescheduling. A congressional committee recently voted to block federal officials from taking further steps to carry out cannabis rescheduling, though bipartisan lawmakers told Marijuana Moment they don’t believe that provision will be enacted into law. Read the DEA judge’s post-hearing order below: The post Federal Marijuana Rescheduling Hearing Wraps Up, With DEA Judge Laying Out Next Steps appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Delaware’s top marijuana regulator is touting changes to cannabis policies that lawmakers passed this session, saying they will “further strengthen” the state’s regulatory framework—even as one measure was enacted despite the veto of the governor who appointed him. The legislature passed a number of reforms this year, including measures to allow terminally ill patients to use medical cannabis in healthcare facilities, regulate THC-infused beverages and address zoning restrictions for marijuana businesses. “These legislative updates provide important clarity and structure as Delaware continues to build a responsible and effective marijuana program,” Marijuana Commissioner Joshua Sanderlin said in a press release on Thursday. “The Office appreciates the work of legislators, stakeholders, and members of the public who contributed to these efforts and looks forward to implementing these changes in a way that supports public safety, regulatory consistency, and transparency.” In May, Gov, Matt Meyer (D) signed a bill to let terminally ill patients use medical cannabis in hospitals. Under the reform, patients and their caregivers will be responsible for acquiring and administering medical marijuana, and it will need to be stored securely at all times in a locked container. Smoking or vaping of medical cannabis will be prohibited, so patients will need to consume it via other methods. Facilities will be able to prohibit medical marijuana use if they determine that such use would have an “adverse impact on the medical care and treatment of the patient or is otherwise contraindicated.” They will also be able to suspend permission to use cannabis if a federal agency such as the U.S. Department of Justice or Centers for Medicare and Medicaid Services takes an enforcement action against such use or “issues a rule, guidance, or otherwise provides notification to health care facilities that expressly prohibits the use of medical marijuana in health care facilities.” Earlier this month, lawmakers voted to override the governor’s veto of a separate bill that would prevent local governments from imposing onerous zoning restrictions on marijuana businesses that make it more challenging for them operate in their jurisdictions. Delaware’s adult-use cannabis market launched last August, with the governor touting the state’s first “successful” weekend of adult-use cannabis sales, with total purchases for medical and recreational marijuana totaling nearly $1 million—and compliance checks demonstrating that the regulated market is operating as intended under the law. But when it comes to local control, Meyer aligned himself with county governments in a way that some lawmakers say is kneecapping the industry with zoning restrictions that limit the expansion of the commercial market. An additional piece of zoning-related legislation enacted this session clarifies that marijuana business spacing requirements apply only to retail dispensaries, letting non-retail operations like cultivation, manufacturing and testing facilities operate without additional spacing restrictions. Another bill passed by lawmakers this year seeks to establish a regulatory and tax framework for the manufacture, distribution and sale of THC-infused drinks. The legislation has not yet been acted on by the governor, however. “These measures represent important progress in ensuring Delaware’s marijuana program continues to operate with clear standards and appropriate oversight,” Sanderlin said. “The Office of the Marijuana Commissioner remains committed to implementing these laws effectively and supporting a safe, transparent, and well-regulated industry.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Separately, a House committee this session approved a bill to decriminalize public consumption of marijuana, but it didn’t advance further. While certain legal marijuana states like Colorado and Ohio still impose criminal penalties for public cannabis use, Delaware stands out as especially punitive, with a maximum penalty that carries the risk of jail time in addition to a fine. Last year, Meyer detailed a conversation he had with Colorado Gov. Jared Polis (D) about regulating the marijuana industry—drawing a contrast between their respective responsibilities given the fact that Colorado is much larger with more local jurisdictions to interact with compared to Delaware, which has just three counties. The launch of Delaware’s legal market came about two years after marijuana legalization was enacted into law under former Gov. John Carney (D). Ahead of the sales roll-out, the current governor last July toured one of the state’s cannabis cultivation facilities, praising the quality of marijuana that’s being produced, which he said will be the “French wine of weed.” The launch of the legal market came with some controversy, however, with critics alleging that allowing medical operators to start adult-use sales ahead of other license applicants is unfair. Dozens of other would-be retailers that have either already received licenses or are still awaiting issuance will need to wait for further regulatory approvals until they can open their doors—a situation that’s frustrated some advocates. Regulators initially projected that recreational sales would start by last March, but complications related to securing an FBI fingerprint background check service code delayed the implementation. Lawmakers passed a bill to resolve the issue, and the FBI subsequently issued the code that the stat’s marijuana law requires. The post New Changes To Delaware Marijuana Laws ‘Provide Important Clarity And Structure,’ Top Official Says appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Senate Democrats have filed a bill to federally legalize marijuana, a far-reaching proposal that comes as the Trump administration is moving ahead with a more incremental reform to reschedule cannabis. The Cannabis Administration and Opportunity Act (CAOA), which is being led by Sen. Cory Booker (D-NJ), Minority Leader Chuck Schumer (D-NY) and Sen. Ron Wyden, along with other Democratic senators, would completely remove cannabis from the Controlled Substances Act (CSA), a process known as “descheduling.” It would also create a pathway for people to get their prior criminal sentences for cannabis reduced and expunged while restoring access to housing, jobs and civil rights that they may have lost. The legislation would additionally apply a federal tax on marijuana and use some of the revenue to create a Department of Justice Cannabis Justice Office that would manage a fund to support job training, reentry and legal aid for people from communities harmed by prohibition. “For decades, generations have suffered unjustly under the failed War on Drugs and broken cannabis laws—hurting primarily people of color. It is long overdue that we stand up for them,” Booker said in a press release. “I am proud to reintroduce this commonsense legislation, which will dismantle the unjust and outdated federal marijuana prohibition, establish a federal regulatory framework to protect public health and safety, expunge past convictions for low-level cannabis offenses, and deliver restorative justice to the communities most harmed by decades of failed drug policy.” The bill filed on Thursday is largely similar to versions that have been filed in the previous two Congresses, though it contains new provisions on hemp. Specifically, it would prevent the federal recriminalization of hemp THC products that is scheduled to take effect in November. The measure’s introduction comes one day after the conclusion of a Drug Enforcement Administration (DEA) hearing on the Trump administration’s proposal to reschedule marijuana from Schedule I of the CSA to Schedule III. Schumer said that “the over-criminalization of cannabis has destroyed far too many lives, disproportionately harming communities of color.” “Our Cannabis Administration and Opportunity Act is necessary and would correct historical wrongs while investing in safety, research, workers’ rights, and banking accessibility for industry,” he said. “The movement is budding, and I won’t stop until restorative justice is achieved. The American people overwhelmingly support the federal legalization of cannabis—it’s long past time the government caught up” Wyden added that “the only reefer madness I’m seeing is the continued federal prohibition of cannabis.” “Our legislation is the most comprehensive proposal on the books to end federal cannabis prohibition while keeping public health and safety front and center,” he said. “The federal government needs to get with the times, and our bill is the way to do it.” Separately, a bipartisan group of senators last month filed a bill to ease marijuana businesses’ access to banking services. CAOA, the federal legalization measure, is being introduced with a total of 17 original cosponsors. In addition to the trio of senators leading the bill, the other members signed on are Sens. Michael Bennet (D-CO), John Fetterman (D-PA), Kirsten Gillibrand (D-NY), John Hickenlooper (D-CO), Ben Ray Luján (D-NM), Alex Padilla (D-CA), Gary Peters (D-MI), Tina Smith (D-MN), Raphael Warnock (D-GA), Ed Markey (D-MA), Jeff Merkley (D-OR), Patty Murray (D-WA), Elizabeth Warren (D-MA) and Peter Welch (D-VT). Here are the key versions of the CAOA as reintroduced: Require the attorney general to finalize a rule removing marijuana from the CSA within 180 days of enactment. Impose a 5 percent federal excise tax on small- to mid-sized cannabis producers, which would gradually increase to 12.5 percent after five years. For large businesses, the tax would start at 10 percent and increase to a maximum of 25 percent. Only those 21 and older would be allowed to purchase recreational marijuana products, as is already the policy in states that have legalized for adult use. Expunge the records of people with low-level, federal cannabis convictions within one year of enactment, while allowing those currently incarcerated over marijuana to petition the courts for relief. Create a federal regulatory framework for the marijuana industry, with the Food and Drug Administration (FDA), the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) and the Alcohol and Tobacco Tax and Trade Bureau (TTB) all playing key roles. Within FDA, there would be a Center for Cannabis Products responsible for regulating “the production, labeling, distribution, sales and other manufacturing and retail elements of the cannabis industry,” according to a summary. The Financial Crimes Enforcement Network (FinCEN) would need to update or issue new guidance clarifying to banks and credit unions that the policy change means that they can lawfully service legitimate cannabis businesses. States could choose to continue prohibiting marijuana production and sales, but they could not prevent transportation of cannabis products between legal states through their jurisdictions. Federal laws would still prohibit trafficking in states that ban marijuana and in legal states that impose laws for trafficking. Establish a grant program to fund non-profit organizations that provide job training, reentry services and legal aid. The program would be managed by a new Cannabis Justice Office under the Justice Department. DOJ grants would also go toward law enforcement hiring and community outreach to combat the illicit market. Separate Equitable Licensing Grant and Equitable Licensing Grant Programs would provide funding for states and localities to promote participation in the industry by minority and low-income people. Further, there would be a 10-year pilot program through the federal Small Business Administration “for intermediary lending” to provide “direct loans to eligible intermediaries that in turn make small business loans to startups, businesses owned by individuals adversely impacted by the War on Drugs, and socially and economically disadvantaged small businesses.” People could not be denied federal benefits due to the use or possession of marijuana or for a conviction for a cannabis offense. That includes preventing the revocation of security clearances for federal employees. Federal employment drug testing for marijuana would also be prohibited, with certain exceptions for sensitive positions such as law enforcement and those involving national security. Physicians with the U.S. Department of Veterans Affairs (VA) would be authorized to issue recommendations for medical cannabis to veterans. There would be measures taken to prevent diversion, including the establishment of a track-and-trace regime. Further, retail cannabis sales would be limited to 10 ounces in a single retail transaction. Federal law would be amended to explicitly state that SBA programs and services available to marijuana businesses and companies that work with them. The Government Accountability Office (GAO) would be required to facilitate a number of studies into marijuana policy—for example evaluations of the societal impact of legalization in states with recreational marijuana laws on the books, including information on impaired driving, violent crime and more. The Bureau of Labor Statistics (BLS) would need to compile demographic data on business owners and employees in the cannabis industry. Employers with federal cannabis permits required under the legislation that violate certain federal labor laws could see their permits rescinded—a bold policy proposal that would make the marijuana industry uniquely labor friendly. The U.S. Department of Health and Human Services (HHS) would be required to work with the National Institutes of Health (NIH) on ways to promote research into cannabis impacts. There would be a specific requirement to study the diversity of marijuana products available for research purposes. The bill calls for an increase in the quantity of cannabis that’s available for study purposes. There would be targeted public education campaigns meant to deter youth consumption. States would also receive funding for initiatives to prevent youth use and impaired driving, which would include money for education and enforcement. The Department of Transportation would be responsible for developing a standard for THC-impaired driving within three years of the bill’s enactment that states would be required to adopt, unless the secretary finds the department is unable to set such a scientific standard. The National Highway Traffic Safety Administration (NHTSA) would be tasked with collecting data on impaired driving, producing educational materials on the issue for states to distribute and carry out education campaigns. Vaping delivery system products that contain added natural or artificial flavors would be banned under the proposal. Cannabis reform supporters cheered the introduction of the bill. “The reintroduction of the CAOA in the Senate represents a critical opportunity for Congress to adopt marijuana reform that prioritizes the health, safety and wellbeing of everyday Americans,” Maritza Perez Medina, director of federal affairs for the Drug Policy Alliance, said in a press release. “Recent federal orders to advance marijuana reform show how far public opinion and our movement have come. A majority of people across the political spectrum recognize that marijuana criminalization has been a failure and support legal regulation that works.” “The question is not if, but how, we continue on the path toward legalization and repair,” she said. “Do we adopt a piecemeal approach that largely benefits corporate interests and stops short of ending criminalization? Or do we embrace a comprehensive approach that ends federal criminalization, removes all barriers to research into health risks and benefits, and ensures that workers, small businesses, and patients have the protections and opportunities they deserve?” Bryon Adinoff, president of Doctors for Drug Policy Reform, said that moving cannabis to Schedule III, as the Trump administration is considering, “would represent an important acknowledgment of medical reality, but it still falls far short of the comprehensive reform that is needed.” “Cannabis would remain within the Controlled Substances Act, preserving many of the barriers that have distorted research, limited product standardization and placed physicians and patients in legal uncertainty for decades,” he said. “The federal government has already effectively conceded that cannabis has accepted medical use in the United States, a position that is incompatible with continued criminalization at the federal level.” “What is ultimately needed is legislation that provides a regulatory framework and full federal descheduling, such as the Cannabis Administration and Opportunity Act, so cannabis policy can finally be approached as a matter of public health rather than criminal law,” Adinoff said. Dasheeda Dawson, board chair for the Cannabis Regulators of Color Coalition, said that “cannabis regulators across the country understand that rescheduling alone does not resolve the core failures of prohibition.” “Instead, it risks creating a two-tiered industry, where federally protected businesses move ahead while justice-impacted communities still bear the burden of enforcement and exclusion. We cannot regulate our way to equity while preserving the same criminal legal framework that caused the harm,” she said. “The CAOA offers a more comprehensive path because it treats cannabis policy as inseparable from restorative justice, community reinvestment, fair market access and protection against monopolization. Real reform means dismantling the architecture of the drug war—not rebranding it.” The Republican majority in the House of Representatives, meanwhile, has advanced legislation this Congress to block the Trump administration from carrying out marijuana rescheduling. The House Appropriations Committee also approved a bill containing a provision to block federal workers’ compensation programs from covering medical cannabis—”regardless of any change in the scheduling of marijuana.” The panel also approved a separate spending bill and attached report that directs federal officials to continue requiring government employees and safety-sensitive workers such as truck drivers and airline pilots to be drug tested for marijuana, “regardless of any future changes to the legal status or scheduling.” Read the full text of the new Senate marijuana legalization bill below: The post Senate Democrats File Bill To Fully Legalize Marijuana Under Federal Law As Trump Moves To Merely Reclassify It appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Marijuana reform opponents are asking a federal court not to let two medical cannabis companies intervene in a lawsuit that seeks to block the Trump administration from moving forward with federally rescheduling the drug. The businesses—MedPharm Iowa, LLC, which does business as Bud & Mary’s, and Tri-Mountain Pure, LLC—moved late last month to join the side of the government in opposing the litigation from prohibitionists. But now, in two separate filings, anti-rescheduling groups that brought legal challenges that have since been consolidated are arguing that the firms should not be allowed to take part in the litigation. Lawyers for Smart Approaches to Marijuana (SAM) and National Drug and Alcohol Screening Association (NDASA) wrote in a brief that the marijuana companies “have not identified any argument they would make that would not be pressed by the government” and, as such, “are not entitled to intervention.” “The motion to intervene should be denied because…they have not shown that the government will not adequately represent their interests in this case,” it says. “Proposed Intervenors fail to demonstrate that their interests diverge from the government’s in any way or that their presentations in the case will differ at all from the government’s. They do not point to any legal argument or strategy they might pursue that will not be pursued by the government. All they offer is a single sentence asserting that they, unlike the government, have ‘private commercial interests’ at stake, namely ‘a specific, focused interest in the transfer of their products to schedule III and the opportunity to register with DEA to ensure their operations do not violate the Controlled Substances Act.'” A separate filing from attorneys for Cannabis Industry Victims Educating Litigators, Kenneth Finn, MMJ BioPharma Cultivation Inc., MMJ Biopharma Labs, Inc., MMJ International Holdings, Inc. and New Directions Addiction Recovery Services similarly says that the cannabis companies “do not identify a single legal argument in defense of the order that Respondents are unable or unwilling to make.” “Their motion instead lists commercial and operational grievances—tax treatment under § 280E, pending registration applications, banking, research, and hiring—that are irrelevant to the issue in this case, namely whether Respondents acted within their statutory authority and observed required procedures.” The opponents of the federal rescheduling move say that to the extent the medical cannabis firms want to shape the litigation, the court could allow them to file amici curiae briefs as outside parties instead of becoming direct participants. Bud & Mary’s, which operates in Iowa, and Tri-Mountain Pure, which is based in Pennsylvania, have both already applied for federal registration using a Drug Enforcement Administration (DEA) form that the agency made available for cannabis businesses seeking protections and benefits that come with rescheduling, and their motion to intervene says they would be “would be directly harmed” if cannabis reform opponents’ challenges are successful. The litigation challenging the federal cannabis rescheduling move is actually comprised of three separately filed lawsuits that have been consolidated by the U.S. Court of Appeals for the District of Columbia Circuit. One suit is led by prohibitionist organization Smart Approaches to Marijuana (SAM) and the National Drug and Alcohol Screening Association (NDASA), who claim they are “aggrieved” by the reform. Another comes from a coalition of anti-marijuana activists, substance misuse professionals, doctors and a cannabis-focused biopharmaceutical corporation. A third challenge was filed by the attorneys general of Indiana, Nebraska and Louisiana—though the later state later withdrew from the suit. Meanwhile, the Department of Justice recently filed a brief opposing marijuana opponents’ request to pause the cannabis rescheduling proposal from moving forward amid the overall litigation—arguing that the drug testing industry association and pharmaceutical company seeking to block the reform have “pocketbook interests served by keeping all marijuana in schedule I.” The developments in the litigation come as DEA this week wrapped up an administrative hearing on the marijuana rescheduling proposal in which government witnesses and lawyers highlighted the medical uses and relative safety of cannabis while opponents challenged the process by which officials developed the recommendation for the reform. Under an action announced by Acting Attorney General Todd Blanche in April, marijuana products regulated by a state medical cannabis license immediately moved from Schedule I of the Controlled Substances Act (CSA) to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA). The hearing is considering broader cannabis rescheduling, including for recreational products. The suit from SAM and NDASA challenging rescheduling was signed by attorneys at Torridon Law PLCC, where former U.S. Attorney General William Barr, led DOJ during Trump’s first term in office, is a partner. SAM had announced in January that it was hiring Barr’s firm to legally combat cannabis rescheduling after Tump signed an executive order directing officials to complete the process expeditiously. Meanwhile, the House Appropriations Committee voted to block federal officials from taking further steps to carry out cannabis rescheduling. Bipartisan lawmakers told Marijuana Moment, however, that they don’t expect the legislative effort to block rescheduling to succeed. Separately, SAM and other plaintiffs filed a lawsuit seeking to block a Trump administration program to cover certain hemp-derived products through Medicare. That case was dismissed by a federal judge in May, but that decision is being appealed. Read the full recent briefs in the marijuana rescheduling lawsuit below: Photo courtesy of Philip Steffan. The post Marijuana Companies Shouldn’t Be Allowed To Defend Rescheduling By Joining Lawsuit, Anti-Cannabis Groups Say appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“Veterans should never have to choose between being truthful with their healthcare providers and worrying that a routine checkbox could quietly become a barrier to care.” By Mary Lynn Mathre, Veterans Action Council The Veterans Action Council (VAC) has obtained thousands of pages of internal Department of Veterans Affairs (VA) records through the Freedom of Information Act (FOIA) as part of an ongoing series, revealing how VA develops cannabis policy and trains its clinicians—but a question has remained: Is VA actually following its own policies? Sometimes the most important evidence doesn’t come from another FOIA request; it comes directly from veterans. Two Veterans attending separate VAC meetings, treated at different VA facilities in states with medical cannabis programs, independently shared similar experiences. In both cases, a routine dental intake form asking about cannabis use appeared to contribute to medical documentation that later influenced healthcare decisions outside the dental clinic. Based on VAC’s collective experience, this appears to be a new development. Cannabis-related pain contracts were common more than a decade ago, and veterans successfully pushed back. Now, similar cannabis-related restrictions appear to be emerging in VA dental care. That raises a troubling question: Can a simple checkbox quietly shape a veteran’s medical record and, ultimately, affect future care without the veteran fully understanding how that information will be used? It matters because VHA Directive 13151, which lays out the department’s overall approach to cannabis, says that veterans should not be denied VA healthcare solely for participating in a state-authorized medical cannabis program or disclosing cannabis use. Yet the records reviewed by VAC suggest that, in at least some states, a dental intake form may carry consequences far beyond the dentist. From Dental Intake To Permanent Medical Record Every day, veterans complete health questionnaires before receiving VA dental care. Along with questions about medications, tobacco use and medical history, many forms ask whether the patient uses cannabis products—including THC, CBD or synthetic cannabinoids. There are legitimate clinical reasons for asking. Cannabis may affect anesthesia, sedation, pain management and medication interactions. Honest disclosure helps providers deliver safe care. But the issue is not the question; it’s what happens after the answer is recorded. The dental intake form reviewed by VAC doesn’t clearly inform veterans that their responses may become part of their permanent electronic medical record, be accessible to providers throughout the VA healthcare system or influence future clinical decisions. Veterans can review their records through the Blue Button feature in VA’s My HealtheVet patient portal, but many don’t discover how their cannabis use has been documented until after it has already affected their care. A notation of “cannabis use” provides little clinical context. It doesn’t distinguish between state-authorized medical cannabis, CBD-only, occasional use or daily THC use, and it doesn’t establish impairment or cannabis use disorder (CUD). Clinical conclusions require clinical assessment, not a checkbox. When Documentation Changes The Story One VAC member’s experience illustrates why this matters. This veteran disclosed cannabis and CBD use during a dental visit. Later, during an unrelated ADHD evaluation, the medical record described the veteran as a “regular cannabis user,” despite no documented assessment of frequency, dosage, purpose, impairment or whether the disclosure primarily involved CBD, which was the case. VAC is not suggesting that every cannabis disclosure leads to this outcome. Rather, this case shows how a brief intake response can become a lasting clinical characterization without documented medical reasoning. CUD is a legitimate DSM-5 diagnosis, but a checkbox, a positive THC test or a simple admission of cannabis use cannot establish it. It requires an individualized clinical assessment using established diagnostic criteria. When cannabis documentation influences referrals, behavioral health evaluations, prescribing decisions or access to care, the medical record should clearly document the clinical basis for those decisions. What VA Policy Requires These cases raise concerns because they appear to conflict with VHA Directive 13151, which states that veterans should not be denied VA healthcare solely for participating in a state-authorized medical cannabis program or disclosing cannabis use. The directive encourages providers to discuss and document cannabis use when medically relevant. It doesn’t support using disclosure alone as a basis for denying care or creating barriers to treatment. If documentation originating in a dental clinic contributes to delays or denials elsewhere in the VA healthcare system, that practice warrants careful review to ensure consistency with Directive 1315. Why This Matters These cases are about more than paperwork. VAC is documenting veterans in multiple states who believe cannabis disclosures made during dental visits later adversely influenced unrelated healthcare decisions. While further investigation is needed to determine the extent of this practice, these patterns raise serious questions about patient safety and the accuracy of ongoing documentation. Medical records follow veterans throughout the VA healthcare system. A note entered during one appointment may later influence decisions by primary care providers, mental health clinicians, specialists, pharmacists and others. The issue is not whether providers should ask about cannabis. It’s whether a routine disclosure, recorded without adequate context, can quietly become a lasting clinical characterization that negatively affects future VA care. What Veterans Should Do Veterans should continue to answer healthcare questions honestly. Accurate information helps clinicians provide safe treatment. At the same time, veterans should provide as much context as possible. If cannabis is used for medical purposes, that should be stated. If the product contains only CBD, that distinction matters. Frequency of use, timing of last use and the medical reason for using cannabis may also be clinically relevant. Veterans should also periodically review their records through Blue Button, paying close attention to provider notes, diagnoses and problem lists. If information appears inaccurate or incomplete, veterans can seek clarification through secure messaging, discuss concerns with their provider, request assistance from a patient advocate or privacy officer or formally request an amendment to their medical record. What VA Should Do VAC believes these cases highlight opportunities to strengthen documentation practices while reinforcing existing policy. VA should ensure that intake forms clearly explain how disclosed information may be used, make forms relied upon in clinical decision-making available within veterans’ medical records, require individualized clinical justification whenever cannabis documentation materially affects treatment decisions and audit cannabis-related delays or denials of care to ensure compliance with Directive 1315. The Bottom Line The experiences shared by VAC members raise important questions about what may be happening in real-world practice. Patients outside the VA system should pay attention to this issue, as what transpires within VA will likely be spreading across the country. VAC’s ongoing cannabis-related FOIA investigation has revealed what official VA policy says should happen. If a routine dental intake form contributes to documentation that later affects healthcare decisions, then the issue extends far beyond just dentistry. It becomes a question of medical record accuracy, transparency and whether veterans can trust that their honest disclosures will be documented fairly and used appropriately. Veterans should never have to choose between being truthful with their healthcare providers and worrying that a routine checkbox could quietly become a barrier to care. A checkbox should initiate a clinical conversation, not serve as a clinical conclusion. Mary Lynn Mathre is co-founder and president of Patients Out of Time and a founding leader of the American Cannabis Nurses Association. She is the editor of Cannabis in Medical Practice and co-editor of Women and Cannabis, and is a patient advocate and a former lietenant in the U.S. Navy Nurse Corps. The post How A Cannabis Checkbox On VA Dental Paperwork Can Shape Veterans’ Medical Records Without Them Ever Seeing It (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

GOP senator on keeping hemp legal; ID medical marijuana ballot rejection details; VA cannabis violation report form; Medical marijuana & veterans Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen. If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Department of War issued a memo warning service members that use and possession of marijuana “remain punishable” even in light of the Trump administration’s move to federally reschedule cannabis. Sen. Tim Sheehy (R-MT) said he is optimistic the scheduled federal recriminalization of hemp THC products this year can be averted—saying forthcoming bipartisan legislation on the issue can bring lawmakers together during a “hyperpartisan time when it appears like we can’t get anything passed.” Idaho’s secretary of state detailed his determination that a medical cannabis campaign failed to submit enough valid signatures to put a legalization initiative on the November ballot—revealing in a new letter that possible illegal petitioning conduct has been referred to the State Police for “review and potential criminal investigation.” The Virginia Cannabis Control Authority launched an online form and tip line for people to report suspected violations of the state’s new recreational marijuana sales legalization law—saying that “every report helps [to] investigate potential violations and protect public health and safety.” U.S. Army veteran Dray Orion argues in a new op-ed that it’s time for South Carolina lawmakers to “an honest conversation about medical cannabis” after years of legislation being filed and failing to pass. / FEDERAL Veterans Affairs Secretary Doug Collins and Health and Human Services Secretary Robert F. Kennedy Jr. posted a video about their departments’ psychedelics partnership. The White House Office of Management and Budget noted that a commenter on a proposed update of the North American Industry Classification System suggested including the cannabis industry. / STATES A federal judge issued a preliminary injunction blocking Ohio officials from enforcing hemp product restrictions against 10 beverage companies. Colorado regulators issued a health and safety advisory about marijuana products with pesticides above acceptable limits. Vermont regulators published updated guidance on marijuana purchase limits and action limits. California marijuana regulators posted a five-year strategic plan. Illinois regulators provided a response to a question about sales of cannabis seeds. The Minnesota Cannabis Expungement Board hosted an event to help people clear past marijuana records. New York regulators extended the deadline to submit abstracts for a medical cannabis symposium to July 24. Pennsylvania regulators posted an updated list of Medical Marijuana Advisory Board members. Michigan officials will hold an event about marijuana taxes on Thursday. The Alaska Marijuana Control Board Laboratory Testing Working Group will meet on Thursday. The Rhode Island Cannabis Control Commission will meet on Friday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / LOCAL The San Francisco, California Board of Supervisors approved a proposal to allow cannabis cafes. Oakland, California’s Cannabis Regulatory Commission will meet on Thursday. / INTERNATIONAL Kenya’s High Court upheld the country’s cannabis criminalization law amid a challenge from Rastafarians. / SCIENCE & HEALTH A study suggested that a CBD-loaded hyaluronic acid–graft-poly nanogel “is a safe and promising delivery system for acne management.” A study found that a single dose of psilocybin reduces both the rapid and sustained fear memory in mice, at least in part by restoring neuroplasticity in the hippocampus and [medial prefrontal cortex],” indicating that “psilocybin has significant potential for use in the treatment of PTSD and other mental disorders characterized by fear memory.” / ADVOCACY, OPINION & ANALYSIS The Hemp Beverage Alliance published a report on wholesale sales data for the industry. / BUSINESS U.S. Customs and Border Protection ruled that a STIIIZY vape does not infringe on any patents in response to an infringement challenge from PAX Labs. Curaleaf Holdings, Inc. received approval for two standardized cannabis preparations from Spanish officials. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Military issues anti-cannabis warning despite rescheduling (Newsletter: July 16, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Add a touch of luxury to your nightlife with Escorts in Chanakyapuri. These glamorous companions combine beauty, confidence, and sophistication to create an enjoyable experience that perfectly matches your mood and occasion.

Your writing is really informative Solano Condo

Hello, I’m Renu. I’m a love living in Jaipur, Rajasthan. I am a fan of love, date, and sex. I’m also interested in relationship and education. You can visit my website with a click on the button above. Rajasthan is home to a unique type of beauty, and the call girls in Jaipur featured on Empire Escort embody this. This state boasts an ancient culture characterized by feminine elegance and a subtly intense sensuality that lies beneath its calm exterior. The women who opt to work independently in this city possess both qualities. Agra call Girl call girl in Goa Bangalore call girl Gurgaon call girl chandigarh call girl Dehradun call girl call girls in Haridwar call girls in Rishikesh call girl in Lucknow call girl in Varanasi call girl in Amritsar call girl in Ghaziabad Udaipur call girl call girl in Ludhiana call girls in Guwahati call girl in Raipur call girl in Patna call girl in Zirakpur call girl in Mohali call girl Kanpur

Arriving in Bhopal for business or leisure? Time is precious, and our Bhopal Call Girl Service respects that. We offer quick, discreet, and reliable companion services designed for the modern traveler. Our girls are verified, elegant, and adaptable — they'll match your schedule and energy. Whether it's a short meeting or an overnight stay, we ensure your experience is seamless and satisfying. Affordable rates start at ₹3999, with cash-on-delivery options for your convenience. Experience Bhopal with a companion who makes every moment count.

Your satisfaction is our only priority. An Escort in Gurgaon brings warmth, charm, and professionalism to every encounter. She is trained to understand your emotional needs and respond caringly. The service is designed to provide complete relaxation and genuine happiness.

I'm glad to see the great detail here!. Water Well Drilling Rig Manufacturer

A Republican senator is previewing forthcoming bipartisan legislation to reverse the scheduled federal recriminalization of hemp THC products this year and replace it with a new regulatory system that includes age limits and taxes. Sen. Tim Sheehy (R-MT) said the issue is “important to me personally” as a wounded veteran “who has a lot of friends who’ve gone through various stages of healing after the war” and also as someone who represents an agriculture-focused state. “I’m optimistic that in a hyperpartisan time when it appears like we can’t get anything passed, this might actually be a subject where we can see both executive and legislative success,” the GOP lawmaker said during a Zoom meeting with members of the group Hemp Industry & Farmers of America (HIFA) on Wednesday. “That’s going to be good for America.” Sheehy said there is a “bipartisan group coalescing around” the issue, citing lawmakers such as Rep. Andy Barr (R-KY) and Sen. Amy Klobuchar (D-MN) who he is partnering with hemp reform legislation that he said will be introduced “relatively soon.” “We’re contemplating a number of legislative actions here that support the hemp industry.” The senator, who has separately championed veterans-focused psychedelics legislation, noted that the Trump administration has been pushing Congress to delay, amend or alter the planned hemp ban and has also been taking steps to accelerate therapeutic access to substances such as psilocybin and ibogaine. “They’ve signaled support for a lot of non-standard treatments, a lot of non-standard drugs, a lot of non-standard substances that historically—by historically I mean hundreds of years ago—have been used for a long time, but in the last 50 years have been restricted from usage,” Sheehy said. Hemp derivatives with less than 0.3 percent delta-9 THC on a dry-weight basis were federally legalized under the 2018 Farm Bill that President Donald Trump signed during his first term in office. But late last year, Trump signed new legislation containing provisions that will redefine hemp to make it so only products with 0.4 milligrams of total THC per container will remain legal after November 12. In a letter to House Speaker Mike Johnson (R-LA) last month, White House Office of Management and Budget (OMB) Director Russell Vought said the administration wants lawmakers to “ensure the fair treatment of hemp products”—specifically citing legislation that would keep many hemp products legal that are currently set to be recriminalized this year, add labeling requirements and institute new taxes on sales, among other regulatory reforms. During the meeting with industry representatives on Wednesday, Sheehy noted how hemp products have “continuously proved to be effective in helping” veterans dealing with PTSD, traumatic brain injury and chronic pain—especially as an alternative to opioids and alcohol. The senator also responded to questions from HIFA members who asked about the specific details of the soon-to-be introduced hemp reform legislation. In response to one person who noted that hemp farmers often have to destroy a significant percentage of their crops due to compliance issues, Sheehy said that his legislation as drafted would raise the threshold for legal hemp crops to 1 percent THC, up from the current 0.3 percent limit. “This has all been obviously crafted with industry and farmer input,” he said. “And we’ve heard from the various stakeholders that they feel this will give enough certainty and flexibility for crop cultivation, that this will give the security and the safety net they need to to be able to invest in this.” Replying to a separate question about taxes on hemp products, Sheehy said that the rate of 5 cents per milligram of THC for beverages that is currently in the bill, along with a 5 percent user fee for other hemp-derived products for interstate commerce, is “a place where the business can thrive.” “It’s still a fair balance between the producers and the taxpayers and the consumers that strikes that middle ground,” he said. “Now, of course, we’ve got to get this passed. It’s got to go through negotiation and conference. That could change.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — On that note, the senator said that the bill is “not going to be perfect out the gate.” “I think in trying to get something done bipartisan and get it approved by the admin and get it passed into law, we’re going to have to accept close enough and good enough initially, and hopefully tweak it later,” he said. Other issues addressed during the call included how to keep children from accessing intoxicating hemp products and protecting the ability of companies to engage in interstate commerce. Ultimately, Sheehy expressed optimism that Congress could pass legislation to keep hemp products legal this year. “When we have an actual profitable crop that there’s genuine free market demand for that crop, and we have the ability to grow that crop in America and sell it profitably with free market enterprise reigning, and it’s not even government subsidized—it’s silly not to let that thrive,” the senator said. “Now, yes, there’s a limit to that. We don’t want to be growing opium and you know heroin all that stuff and cocaine,” he said. “I get it, but this is not that. And I think it’s important that we institute a legal framework around this because if we don’t, it’ll always be perceived as one of these. It’ll still be tucked in the corner of a fringe drug that’s bad and has to be banned. I think if we bring it into the light, we regulate it, we provide a framework around it. It’s going to be accepted it’s going to thrive.” Meanwhile, the former head of the Department of Homeland Security under the first Trump administration recently sent a letter warning congressional against keeping hemp THC products legal, claiming that reversing the ban that is set to take effect later this year would “undermine public health” and “embolden foreign criminal actors.” The Trump administration, however, “welcomes the opportunity to work with the Congress to, at a minimum, update the statutory definition of final hemp-derived cannabinoid products to allow Americans to benefit from access to appropriate full-spectrum CBD products,” OMB separately said last month, “while preserving the Congress’s intent to restrict the sale of products that pose serious health risks.” The call to avert a broad prohibition on hemp CBD products was included in a statement of administration policy about an annual agriculture spending bill that passed the House of Representatives. Several lawmakers had filed amendments to that legislation to keep hemp products legal, but each was either blocked by the House Rules Committee from advancing to a floor vote or withdrawn by its sponsor. “The Administration supports advancement of this legislation, but looks forward to addressing its concerns prior to enactment,” OMB said in its statement of administration policy. “The Administration looks forward to working with the Congress to provide more input as the bill’s legislative process unfolds.” In April, the president himself urged congressional lawmakers to again redefine hemp to avoid recriminalization of full-spectrum CBD products. “I am calling on Congress to update the Law to ensure that Americans can continue to access the full-spectrum CBD products they have come to rely on, and that help them, while preserving Congress’s intent to restrict the sale of products that pose Health risks,” Trump said in a Truth Social post on the same day his administration announced it is moving forward with rescheduling marijuana. “We must get this done RIGHT and FAST, especially for those who saw that CBD helps them,” he said. “Plus, I am told it will also help our GREAT FARMERS, who we love, and will always be there for.” Industry advocates say that the law as enacted last year not only threatens to prohibit intoxicating and synthetic cannabinoid products but also stands to remove popular full-spectrum CBD products that many Americans use therapeutically from the market. “ONE in FIVE adults used it in the past year, and many say it improved their chronic pain enormously,” the president said in his social media post, adding that hemp-derived CBD “has made a HUGE difference for so many people.” He also referenced a new initiative the administration launched in April to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. The program being implemented by the Centers for Medicare & Medicaid Services (CMS) focuses largely on CBD but also allows products to have up to 3 milligrams of total THC per serving. “In December, I signed a very important Executive Order calling for Research and Innovation for Hemp-derived CBD,” Trump said. “Our wonderful Dr. Mehmet Oz moved fast to follow the directive in the Executive Order, and launched a model for some Seniors earlier this month. But more must be done!” “Please get it done, and SOON,” the president said in reference to a congressional fix for the broad recriminalization set to take effect in November. “Thank you for your attention to this matter!” It’s not clear how far Trump wants to scale back the scope of the scheduled federal restrictions on hemp products and what kinds of revised THC rules and limitations he would prefer to sign into law. As Marijuana Moment reported last month, a Republican congresswoman is circulating draft legislation that would keep hemp THC beverages legal under federal law, creating a carve-out from the broad recriminalization of products derived from the crop that is set to take effect later this year. The Hemp-Derived Beverage Regulatory Clarity Act from Rep. Beth Van Duyne (R-TX), in its current form, would allow adults over 21 to purchase and consume hemp THC drinks with up to 5 milligrams of delta-9 THC per serving. It would also impose a federal tax of 10 cents per milligram of any hemp-derived cannabinoid contained within such beverages. The National Restaurant Association, which represents the industry, recently sent a letter urging congressional leaders to delay the federal recriminalization of hemp THC beverages that is scheduled to take effect later this year and replace it with a regulatory framework that “ensures consumer safety while meeting growing market demand” for the products as an alternative to alcohol. A U.S. Department of Agriculture report published in April shows that farmers in the U.S. grew three-quarters of a billion dollars worth of hemp crops in 2025—a 64 percent increase from the prior year. The post GOP Senator Says Keeping Hemp THC Products Legal Is An Issue That Can Unite Lawmakers At A ‘Hyperpartisan’ Time appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

“This is not about turning South Carolina into something it is not. This is about compassion, medical freedom and common sense.” By Dray Orion, U.S. Army veteran via South Carolina Daily Gazette I came home from war with things I could explain and things I still cannot. Some of it was physical. Some of it was mental. Some of it was the kind of weight that does not show up cleanly on a chart, in a scan or in a polite conversation. Any veteran reading this knows exactly what I mean. You can look fine from the outside and still be carrying a battlefield inside your chest. That is why I believe South Carolina needs to have an honest conversation about medical cannabis, especially for veterans. Not a political shouting match. Not a culture-war circus. An honest conversation. Because right now, too many veterans are left with the same old choices. Take the pills. Tough it out. Drink it down. Stay quiet. Pretend you are fine. Smile at the cookout. Sit alone in the garage. Carry the nightmares. Carry the pain. Carry the shame. And if you find something that helps, but the law has not caught up yet, you are suddenly treated like the problem. That is backwards. I am not writing this as someone trying to sound edgy. I am writing this as a veteran, a father, a husband, an author and a man who has had to learn how to keep living after war. I am also a disabled veteran, though I do not usually lead with that. Truthfully, I do not even like people knowing it most of the time. Not because I am ashamed of my service, but because people look at you differently when they hear those words. They start seeing the injury before they see the person. They start treating your life like a sad story instead of a life you are still trying to build. I have watched too many good people suffer in silence because they were afraid of being judged, punished or dismissed. Veterans are trusted to carry rifles overseas. We are trusted to make life-and-death decisions in places most people will never see. But when it comes to our own pain, suddenly we are not trusted to have a legal medical option that may help some of us sleep, eat, calm down, function or simply get through the day without feeling like we are crawling out of our own skin. That does not make sense to me. Medical cannabis is not magic. It is not a cure-all. It is not for everybody. No serious person should pretend otherwise. But we should also stop pretending that the current system is working for everyone. It is not. We also need to be honest about what we already accept. Alcohol is legal for adults over 21, even though the Centers for Disease Control and Prevention says excessive alcohol use kills about 178,000 people a year in this country. Meanwhile, the Drug Enforcement Administration’s marijuana fact sheet says no deaths from marijuana overdose have been reported. That does not mean cannabis is harmless. It means our laws are not always based on honest comparisons of risk. For some veterans, the issue is post-traumatic stress syndrome. For others, it is chronic pain, anxiety, sleep, appetite or the long-term damage that comes from years of service, injuries, medications and stress. Some are doing everything “right” and still suffering. And here in South Carolina, many of them are expected to suffer quietly or leave the state to access something that should be available safely and legally at home. That is the part that gets me. This is not about turning South Carolina into something it is not. This is about compassion, medical freedom and common sense. It is about building a regulated system that gives seriously ill people, including veterans, access to medical cannabis under the care of professionals. South Carolina lawmakers have had chances to move this conversation forward. The Compassionate Care Act, which has failed repeatedly, has been an attempt to create a regulated medical cannabis program for people who are suffering and whose doctors believe it may help. We already know veterans are struggling. We already know suicide, addiction, isolation and untreated trauma are real issues in our communities. So why are we still making this harder than it has to be? Whenever people find out I served, the usual response is, “Thank you for your service.” I know most people mean that kindly, and I do not take it lightly. But I will be honest—it has never sat completely right with me. I volunteered. I raised my hand. I made that choice. A thank-you is appreciated. But it is not a treatment plan. It is not a policy. And it is not enough. I live in Rock Hill. I care about this state. I care about the people here. I care about the veterans in church pews, grocery store lines, job sites, classrooms and quiet living rooms carrying things they do not talk about. Some of them will never stand at a microphone. Some of them will never tell their story because the weight of it is too personal, too complicated, or too painful. South Carolina veterans deserve more than gratitude once a year and a discount at a restaurant. They deserve options. They deserve dignity. We do not need more silence. We need courage. And compassion. And laws that finally reflect both. Dray Orion is a retired U.S. Army veteran who served between 1993 and 2009, with multiple deployments, including Saudi Arabia and Iraq. He is also an author and father. His debut book, “Living Out Loud: No Shame, No Chains,” is about shame, identity, survival, and the courage it takes to live honestly. He lives in Rock Hill. This piece was first published by South Carolina Daily Gazette. The post It’s Time For South Carolina Lawmakers To Take Medical Marijuana Seriously, Military Veteran Says (Op-Ed) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Idaho’s top elections official is explaining his determination that a campaign for an initiative to legalize medical marijuana did not submit enough valid voter signatures for the measure to appear on the November ballot. He also said that possible illegal petitioning conduct has been referred to the State Police for “review and potential criminal investigation.” Secretary of State Phil McGrane (R) wrote in a letter to the campaign on Monday that his office received “received numerous complaints concerning the petition process” for the marijuana initiative—adding that “even under the most favorable assumption” that every petition sheet turned in was timely filed and that every submitted signature was valid, activists still wouldn’t have met minimum requirements. To be certified for the ballot, the team needed to submit signatures from at least 6 percent of registered voters as of the state’s last general election, which currently amounts to 70,725. They also needed to meet that 6 percent threshold in at least 18 of the state’s 35 legislative districts. “The petition contains no more than 58,024 county-certified signatures and meets the six-percent legislative-district threshold in only thirteen (13) districts. It is therefore 12,701 signatures short of the 70,725- signature statewide requirement and five (5) legislative districts short of the eighteen-district requirement,” the secretary of state wrote. “Those shortfalls are independently dispositive and exist before any signature or petition sheet is excluded because of the additional issues described below.” “The statutory circulation and filing deadlines have passed, so additional signatures cannot now be gathered or submitted to cure either shortfall,” McGrane said. The secretary of state’s letter details a number of specific alleged issues with the medical cannabis campaign’s petition drive. Idaho state law requires that people who circulate initiative petitions be residents of the state, but “complaints and county-clerk records identified numerous circulator affidavits in which the circulator attested to Idaho residency while listing an out-of-state address,” the letter says. “In certain instances, county clerks also reported that a circulator presented an out-of-state driver’s license after being asked for identification.” “The Office notified you of these concerns, provided lists of circulators whose residency could not be verified, requested supporting documentation by June 30, 2026, and explained the statutory consequences of nonresidency. Based on materials later provided by your organization, the Office was able to confirm residency for ninety-five (95) circulators. As of the Office’s follow-up review, however, residency remained unconfirmed for 293 circulators reflected in county-clerk records and campaign-finance reports. The available records substantiate the residency concern as to certain circulators and leave material residency questions unresolved as to others.” Another issue detailed in the letter is the allegation that “a majority, if not all, of the petition packets” submitted by the cannabis campaign failed to include required introductory language and a warning that it is a felony for someone to sign a ballot petition with a name other than their own or to sign a petition more than once. “Because the issue appears across the submitted petitions, it raises a broader concern about whether the petitions were circulated in the form required by law,” McGrane said. “This concern is separate from, and adds to, the signature shortfalls described above.” The letter further says that one county “transmitted a petition sheet containing a signature attributed to a person whose voter record reflected that the person had died in 2021.” The sheet also contains entries associated with voter records that had been removed from the voter rolls. “Similarities in the handwriting and voter information raised a credible concern that prior voter information may have been used to create purported signatures,” the secretary of state wrote. “The Office has referred this matter and other isolated complaints to the Idaho State Police for review and potential criminal investigation under applicable law.” Finally, the letter cites “discrepancies” regarding an alleged campaign finance compliance issue related to required disclosures for paid petitioners. “Although reports were later amended and additional names were added, the Office’s latest reconciliation identified approximately 175 paid circulators appearing in county records who were not properly identified in the applicable campaign-finance reports,” it says. Activists with the Natural Medical Alliance of Idaho (NMAI), which was behind the medical cannabis initiative, said in a statement on Tuesday that organizers are “shocked that the initiative did not qualify for the ballot,” placing the blame for the failure to turn in enough valid signatures on the first petitioning contractor it engaged before switching to a different firm late in the drive. “NMAI organizers oversaw this effort actively and in good faith. As the campaign progressed, we saw signs that our original signature gathering vendor’s operation was disorganized, but when concerns were raised we were assured that legal requirements, including requirements related to reporting and residency, were being followed and signatures were on pace to surpass the threshold. It appears that our confidence was misplaced. The Secretary of State’s letter describes missed deadlines, circulator documentation and payment disclosures, and petition materials prepared incorrectly or submitted late. We take every claim in that letter seriously and no one wants answers more than we do. We believe every statement made in the letter originated with our initial vendor. None of our concerns extend to the second firm we brought in late in the drive, whose work was professional throughout. NMAI has zero tolerance for signature fraud or prohibited conduct and will cooperate fully with any review.” The campaign said it is now “examining every legal and procedural remedy available, and whatever comes next, the need remains.” “The demand Idahoans expressed through this campaign is not going away,” NMAI said. “Idahoans deserve the right to make their own healthcare decisions and a government that trusts them to do so.” While the cannabis campaign submitted more than 150,000 total signatures in May, there were some recent indications that there could be an issue meeting the county-level requirement as well as potentially the statewide total. A judge ruled last month that signatures in Minidoka County were turned in too late to be counted. Separately, some petitions for the medical cannabis measure throughout the state were at risk of being thrown out due to the possibility they may have been collected by out-of-state circulators. Meanwhile, voters in November will see a different kind of cannabis proposal on the ballot: A constitutional amendment that the legislature approved to make it so only lawmakers could legalize marijuana or other controlled substances—preventing the reform from being enacted by voters via a future ballot initiative. While NMAI pursued ballot access for the legalization measure, Idaho lawmakers have also pushed back in other ways. Both the Senate and House of Representatives passed a resolution this session urging voters to “reject” the medical marijuana petition. The measure, sponsored by the Senate State Affairs Committee, claims that cannabis legalization in other states has led to a host of harms, including “increased cartel activity, development of black market marijuana production, human trafficking, and increased crime rates” as well as “increased rates of serious health issues,” environmental harms and “safety concerns on job sites.” It argues that the marijuana initiative would not only increase costs to the state but that its list of approved medical conditions is “so broad that almost anyone could qualify.” “The Idaho Medical Cannabis Act lacks safeguards to such an extent that it would effectively legalize widespread recreational use of marijuana,” the resolution claims. “The legalization of marijuana would have devastating impacts on Idaho children and their families… The Legislature urges the citizens of Idaho to reject any effort to bring the Idaho Medical Cannabis Act to the ballot.” A statement of purpose filed with the legislation says it “addresses the devastating impact that legalizing marijuana has had on other states” and “identifies the significant problems” with the ballot initiative. Contrary to the claims made about marijuana reform in the legislative resolution, advocates often point to data showing that legalizing and regulating cannabis diminishes the size of the illegal market and has not led to increases in youth use. Meanwhile, NMAI recently released an analysis showing that Idaho could see more than $100 million worth of medical marijuana sold on an annual basis and up to $28 million in new yearly revenue for state coffers if voters approved the legalization initiative. The Idaho Medical Cannabis Act, which NMAI unveiled last October, would provide patients with qualifying conditions access to marijuana from a limited number of dispensaries and provide a regulatory framework for the market. Here are the main provisions of the Idaho Medical Cannabis Act: Health practitioners would be able to recommend medical cannabis to patients with conditions that include, but are not limited to, cancer, anxiety and acute pain. Medical marijuana patients or their designated caregiver could purchase up to 113 grams of smokeable cannabis, or 20 grams of THC extract for vaping, per month. The state would be start by issuing three vertically integrated cannabis business licenses, after which point it could license up to six total. Marijuana would be reclassified under state law as a Schedule II, rather than Schedule I, controlled substance. State and local law enforcement would be barred from assisting in federal drug enforcement activities related to the state-legal cannabis program. There would be anti-discrimination protections for those who use or sell marijuana in compliance from state law, preventing adverse actions by employers, landlords and educational institutions. It does not appear that there would be any equity-centered reforms, nor would the initiative provide for a home grow option. The campaign in February also released the results of a statewide poll showing that 83 percent of likely voters back medical cannabis legalization, including 74 percent of Republicans, 95 percent of Democrats and 92 percent of independents. Asked how they would vote if the current medical cannabis legalization does appear on the November ballot, 76 percent of respondents said “yes.” Of that cohort, 50 percent said they would “definitively” vote yes, and just 21 percent said they’d vote “no.” After the medical cannabis initiative was unveiled last year, a separate campaign that launched in 2024, Kind Idaho, told supporters that it would be suspending its own signature gathering for a ballot initiative to legalize the personal possession and cultivation of marijuana by adults. Kind Idaho previously introduced medical marijuana ballot measures intended to go before voters in both the 2022 and 2024 elections, but the efforts proved unsuccessful. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Legislators separately held a hearing last year to discuss a bill to enact medical cannabis legalization legislatively, but there hasn’t been meaningful action on the issue in the months since. Idaho Gov. Brad Little (R) last year signed legislation setting a $300 mandatory minimum fine for marijuana possession. A prior version of the proposal, which did not pass, would have set a $420 mandatory minimum fine for possessing cannabis. Read the secretary of state’s letter about the medical cannabis petitions below: The post Idaho Official Explains Why Medical Marijuana Initiative Will Not Appear On November Ballot appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Virginia marijuana regulators have launched a new online form and tip line through which people can report suspected violations of the state’s newly enacted law legalizing recreational cannabis sales. The legislation, passed as part of a large-scale budget bill, included a directive for the Virginia Cannabis Control Authority (CCA) to “establish, advertise, and administer a tip line, which may be accessed by phone and by internet, for members of the public to anonymously report concerns about, or suspected instances of, illicit retail marijuana practices in violation of this subtitle.” Now, CCA is following through with the form and the phone line. “Help us protect Virginia’s cannabis market,” CCA said. “Every report helps the Virginia Cannabis Control Authority investigate potential violations and protect public health and safety.” With the online form, people submitting reports can choose whether or not to remain anonymous and can choose from the following activity types: Counterfeit or unregistered products Diversion from licensed facility Illegal advertising Illegal cultivation or manufacturing Illegal delivery Illegal sale Sale to a minor Unlicensed sales Other The form also has fields to report the date, time and location of the allegedly illegal activity, and people also have the option to upload fils in support of their tips. People can also submit tips by calling 1-844-WEED-TIP (1-844-9333-847). CCA is also conducting a survey to gather input from the public and stakeholders as officials work to implement the state’s newly enacted law legalizing recreational cannabis sales. Meanwhile, current and former elected officials have clashed in recent days over allegations that lawmakers inadvertently erased all of the state’s cannabis-related penalties for a period of a year due to errors in enactment clauses in the recently passed marijuana legislation. Late last month, the Virginia Senate and House of Delegates adopted Gov. Abigail Spanberger’s (D) proposed amendments to budget legislation containing provisions to legalize recreational cannabis sales that they had given initial approval to previously. Because lawmakers accepted her suggested changes in full, the measure was immediately formally enacted into law and didn’t require any further action from the governor. Spanberger in May vetoed a previous measure to legalize recreational cannabis sales after lawmakers rejected her proposed amendments to the plan. She later negotiated with Sen. Lashrecse Aird (D) and Del. Paul Krizek (D), who sponsored the earlier measure, on a compromise deal that was included in the budget legislation that passed. The new plan differs significantly in several ways from the earlier legislation. For example, it sets the launch date for recreational marijuana sales at July 1, 2027, which is what Spanberger proposed in contrast to the January 1 date in what lawmakers had passed. It also sets the legal public marijuana possession and per-transaction purchase limit at 2 ounces, an increase from the current legal limit of one ounce. The legislation lawmakers passed earlier this year would have allowed adults to possess up to 2.5 ounces. The bill also cedes to Spanberger on language to increase a marijuana excise tax from 6 percent to 8 percent after two years of legal sales. By way of compromise, the new agreement will make public consumption of marijuana punishable by a civil penalty of $250—a significant increase from the $25 in current law but less harsh than the class 4 criminal misdemeanor the governor sought in her proposed changes to the previous bill. Lawmakers passed the initial cannabis sales bills in March, but the governor then suggested changes to the legalization proposal—including delaying the start date for sales by six months, increasing taxes and instituting new criminal penalties for cannabis consumers. The legislature in April declined to take up the amendments during a one-day reconvened session, however, effectively rejecting them. Spanberger then issued a veto. Spanberger said in June that she was having “really productive” and “incredible” conversations with lawmakers about crafting a compromise approach to legalizing adult-use cannabis sales, and Marijuana Moment previously reported on the ongoing talks. The governor, meanwhile, has tried to publicly explain her veto—including by saying it is her view that “taking a little bit longer” to launch the market is not something she sees as “negative” because it is more important to get the details right than to do it fast. A recent survey found that bipartisan majorities of Virginia voters wanted Spanberger to sign the cannabis legislation into law, and that they specifically disagreed with her desire to slow the launch timeline for legal sales. The governor recently acknowledged in a separate interview that “a lot of people are not pleased” with her veto of the cannabis legislation. “Friends and family are displeased as well,” she said. Spanberger has repeatedly responded to criticism of her cannabis amendments from the bill sponsors and advocates by saying the suggested changes came after she spoke to the leaders of other states that have already implemented adult-use marijuana markets. A spokesperson for Spanberger declined to name any other governors she talked to about cannabis in response to a question from Marijuana Moment, however. The governor separately sought to explain her veto in an earlier interview, reiterating that she supports launching a legal cannabis market but worried about what she called a “rushed timeline” and “far more stores across Virginia” than she thinks are appropriate. Personal marijuana possession and home cultivation of marijuana has been legal in Virginia since 2021, but then-Gov. Glenn Youngkin (R) twice vetoed bills to provide consumers with a way to legally purchase regulated adult-use cannabis. Here are the key details of the new cannabis plan in the budget and how it compares to legislation that Spanberger vetoed—SB 542 and HB 642—as well as her previously proposed amendments to those measures: Adults will be able to purchase up to 2 ounces of marijuana in a single transaction, or up to an equivalent amount of other cannabis products as determined by regulators. That will represent an increase from the limit in current law of 1 ounce. Lawmakers previously proposed setting the amount at 2.5 ounces and the governor only wanted 2 ounces. Legal sales can begin on July 1, 2027. Lawmakers previously set the date for January 1, 2027, but the governor wanted it pushed back to July 1. There will be an excise tax of 6 percent on cannabis sales as well as a 5.3 percent retail sales and use tax, and municipalities will be allowed to set an additional local tax of up to 3.5 percent. Starting on July 1, 2029, the state excise tax will increase to 8 percent, in line with the governor’s previously proposed amendments. Revenue will be distributed to the Cannabis Equity Reinvestment Fund, early childhood education, the Department of Behavioral & Developmental Health Services and public health initiatives. The earlier measure passed by lawmakers would have allocated specific percentages to each, but the new language doesn’t specify what portion of revenue will go to each program. The governor, in her amendments, wanted to put all revenue into the general fund while earmarking it “for purposes such as early childhood education, behavioral health, public health awareness, prevention, treatment, and recovery services, workforce development, reentry, indigent criminal defense, and targeted reinvestment in historically disadvantaged communities.” Her amendment also sought to eliminate support for the Cannabis Equity Reinvestment Fund. The Virginia Cannabis Control Authority will oversee licensing and regulation of the new industry, and will also take on oversight of hemp, which is currently under the Department of Agriculture and Consumer Services. The body will be governed by a five-member board of directors appointed by the governor, whereas the bill previously passed by lawmakers contemplated a seven-member body with four appointed by the governor, two appointed by the speaker of the House and one appointed by the Senate Rules Committee. The definition of what constitutes a legal hemp product will be narrowed by removing a provision from current law that allows those containing more than 2 milligrams of total THC per package if they also have a ratio of CBD to THC that is 25:1 or more. Up to 350 retail marijuana stores will be allowed to be licensed to operate across the state, the same number that lawmakers had approved and greater than the 200 the governor had proposed. Local governments will not be able to opt of allowing marijuana businesses to operate in their area. Delivery services will be allowed. Serving sizes will be capped at 10 milligrams THC, with no more than 100 mg THC per package. Public use of marijuana will be a civil violation punishable by a $250 fine. That is ten times more than the $25 fine under current law, but less harsh than the class 4 criminal misdemeanor crime the governor had proposed. Possession of cannabis by people under the age of 21 will be punishable by a $25 fine and mandatory participation in a substance abuse treatment or education program or both. The governor had suggested treating underage possession as a class 1 misdemeanor, punishable with a mandatory minimum fine of $500 or 50 hours of community service, as well as the suspension of drivers licenses for at least six months. Existing medical cannabis operators can enter the adult-use market if they pay a $10 million licensing conversion fee. Cannabis businesses will have to establish labor peace agreements with workers. A legislative commission will be directed to study adding on-site consumption licenses and microbusiness cannabis event permits that would allow licensees to conduct sales at venues like farmers markets or pop-up locations. That provision was also included in the earlier legislation lawmakers passed but was suggested for deletion by the governor. Meanwhile, the governor signed several other reform bills this session—including measures to provide resentencing relief for people with past cannabis convictions, protect the parental rights of marijuana consumers and allow patients to access medical cannabis in hospitals. The post Virginia Marijuana Officials Are Asking People To Report Violations Of The State’s New Legalization Law With A New Web Form And Tip Line appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

The Department of War (DOW) has issued a memo to senior Pentagon leadership making clear that marijuana use by military service members and civilian employees of the department remains prohibited, even as the Trump administration is moving to federally reschedule cannabis. DOW “maintains a drug-free workplace to protect national security, public safety, and operational readiness,” the one-page document dated July 9 and obtained by Marijuana Moment says. Under an order issued by U.S. Acting Attorney General Todd Blanche in April, marijuana products regulated by a state medical cannabis license immediately moved from Schedule I of the Controlled Substances Act (CSA) to Schedule III, as did any marijuana products that are approved by the Food and Drug Administration (FDA). An ongoing administrative hearing is considering broader marijuana rescheduling. The new Pentagon memo, which has not previously been reported, seems to not recognize that medical cannabis rescheduling has already occurred, however, saying that “if implemented,” the reform “would not decriminalize marijuana under Federal law.” “Service members are reminded that the Uniform Code of Military Justice (UCMJ) prohibits certain actions, including the wrongful use, possession, manufacture, or distribution of marijuana, and attempts to commit such acts,” Anthony J. Tata, the under secretary of war for personnel and readiness, wrote. “These offenses remain punishable under the UCMJ, even if a State or local jurisdiction legalizes the use of recreational marijuana or authorizes the sale of marijuana, including medical marijuana, at State dispensaries.” Lynn Wagner, the executive director of DOW’s Office of Drug Demand Reduction, is listed as a point of contact on the memo, though she did not immediately respond to Marijuana Moment’s request to verify the document, nor did the Pentagon’s press office. “Service members who violate the UCMJ may be held appropriately accountable, including through judicial, nonjudicial, or administrative action,” Tata wrote in the memo, adding that civilian employees of DOW are subject to restrictions of the department’s Drug-Free Workplace Program. “These prohibitions do not apply to formulations approved as drugs by the FDA with a valid prescription for a legitimate medical purpose,” he concluded. The Congressional Research Service, however, published a report on the cannabis rescheduling move explaining that certified patients who possess medical marijuana from state-licensed dispensaries now have certain protections under Schedule III. “The order appears to authorize end users to possess marijuana for medical use without a CSA-compliant prescription,” it says. The Army, meanwhile, enacted a new policy in April making it so recruits will no longer need to obtain a waiver to enlist if they have a single conviction for possessing marijuana or drug paraphernalia on their records. That said, military branches have regularly warned service members about the consequences of using marijuana or even federally legal hemp-derived products. In May, for example, the Army published a post reminding soldiers of its “zero-tolerance” policy for all forms of cannabis and its derivatives—including hair care products and lotions made from hemp. Last year, a memo to Air Force personnel in Massachusetts warned that not only marijuana but also hemp-derived cannabinoids, including CBD and delta-8 THC, are prohibited on military bases and related properties. In 2022, the Air Force expressed concern that even using CBD-infused hand sanitizer or hemp granola could inadvertently compromise “military readiness.” DOD broadly reaffirmed that CBD is off limits to service members in notices published in 2020. The Navy, for its part, issued an initial notice in 2018 informing ranks that they’re barred from using CBD and hemp products no matter their legality. Then in 2020 it released an update explaining why it enacted the rule change. The Coast Guard said in 2019 that sailors can’t use marijuana or visit state-legal dispensaries. Read the full DOW marijuana memo below: The post Military Warns That Trump’s Marijuana Rescheduling Move Doesn’t Allow Use By Service Members appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

HHS/VA psychedelics partnership; ID medical marijuana push fails; CA data: Local bans boost illicit market; Study: Cannabis-infused tea & happiness Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Hold on, just one second before you read today’s news. Have you thought about giving some financial support to Marijuana Moment? If so, today would be a great day to contribute. We’re planning our reporting for the coming months and it would really help to know what kind of support we can count on. Check us out on Patreon and sign up to give $25/month today: https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW The Idaho Secretary of State’s Office announced that medical cannabis activists failed to submit enough valid signatures to qualify a legalization initiative for the November ballot. The Department of Health and Human Services and Department of Veterans Affairs launched a new effort to partner on psychedelic medicine development as other federal agencies also announced support for research on ibogaine’s therapeutic value. A new Congressional Research Service report lays out lawmakers’ options for how to address a federal law barring users of marijuana and other illegal drugs from possessing guns following a Supreme Court ruling that upheld cannabis consumers’ Second Amendment rights. “Congress might opt to amend the law to more narrowly capture only those individuals who may, because of their use or the nature of the drug involved, present a danger to themselves or others.” New data released by the California Department of Cannabis Control reveals that 97 percent of marijuana seized in unincorporated areas of the state came from counties that continue to ban licensed growers. “When local governments deny consumers access to licensed retailers, the illicit market and organized crime benefit, while public health and safety is harmed.” A new study found that drinking marijuana-infused tea leads to a “statistically significant increase in happiness levels” and improvements in sleep—without any negative reported side effects. “Cannabis-infused tea enhanced the state of happiness without reported side effects. Therefore, this prototype tea could be consumed at the optimum dose to maintain health and well-being.” More Maryland social equity marijuana dispensaries are starting to open this year after a slow start to market participation by people who come from communities—or who attended schools in parts of the state—that were disproportionately affected by the war on drugs. / FEDERAL Rep. Kevin Mullin (D-CA) filed a bill to ban retail and online sales of nitrous oxide products to consumers. The House bill to federally legalize marijuana got one new cosponsor for a total of 74. The House bill to create a cannabis-focused scholarship program got two new cosponsors for a total of three. / STATES Ohio Libertarian gubernatorial candidate Don Kissick said he supports lowering marijuana taxes. Oklahoma’s attorney general touted enforcement actions against medical cannabis dispensaries suspected of illegal activity. A Pennsylvania representative celebrated the lack of marijuana legalization language in budget legislation, saying that “aside from being federally illegal, we heard horror stories from other states saying much of the revenue brought in by legalization was canceled out by an increase in funding needed for Medicaid and mental health services.” New York regulators published guidance about including cannabis brand information in the state’s track-and-trace system. Washington, D.C. regulators upheld the rescission of a medical cannabis retailer application. Maine regulators sent a warning about a scam involving phone calls from people purporting to represent the state Office of Cannabis Policy. Virginia regulators published an overview of the Cannabis Public Health Advisory Council. California regulators sent updates on various cannabis issues. The New Jersey Cannabis Regulatory Commission will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / INTERNATIONAL Thailand’s deputy interior minister launched a crackdown on illegal cannabis sales. Namibia’s High Court rejected a case seeking to overturn marijuana prohibition. / SCIENCE & HEALTH A study found that treatment with cannabis-based medicinal products “was associated with improvements in [health-related quality of life], anxiety, and sleep outcomes in autistic patients over an 18-month period.” A case report “highlights a potential adjunctive role for cannabidiol in refractory [paroxysmal sympathetic hyperactivity] following severe” traumatic brain injury. / ADVOCACY, OPINION & ANALYSIS The Josh Kesselman Foundation for Making the World a Better Place is a new foundation focused on supporting cannabis reform and other issues. / BUSINESS The founder of Gold Flora and other cannabis companies is facing federal charges of illegally obtaining pandemic-related loans. A lawsuit that former Arkansas Gov. Mike Huckabee (R) filed against Meta Platforms, Inc. over alleged scam ads that use his name, image or likeness to sell CBD products was revived by the U.S. Court of Appeals for the Third Circuit. / CULTURE Sacha Baron Cohen pretended to be selling marijuana as his character Ali G during an appearance at the Wimbledon tennis tournament. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: The post Congress’s options for addressing cannabis user gun ban (Newsletter: July 15, 2026) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

A balanced lifestyle, regular physical activity, and proper rest are the foundation of lasting health. I also came across best sex stamina pills, which are formulated with herbal ingredients that may support vitality, confidence, and overall stamina as part of a healthy daily routine.

Positive site, where did u come up with the information on this posting?I have read a few of the articles on your website now, and I really like your style. Thanks a million and please keep up the effective work. situs toto

Why settle for less when Gurgaon Escorts Service offers the best in the industry? Their team is well-trained to handle every detail of your appointment, from initial inquiry to the final meeting. Using a professional Escorts Service Gurgaon ensures that you stay safe and comfortable, allowing you to relax and enjoy the company of a stunning woman tonight.

I am impressed. I don't think Ive met anyone who knows as much about this subject as you do. You are truly well informed and very intelligent. You wrote something that people could understand and made the subject intriguing for everyone. Really, great blog you have got here. 인디고 게임

In college, facing a research paper on sustainable urban planning, I felt like I was climbing a steep Slope. The topic was vast, sources conflicting, and my ideas unformed. I eventually focused on community gardens, finding my voice in their connection to local food systems.